Aditxt, Inc. (NASDAQ:ADTX) Short Interest Update

Aditxt, Inc. (NASDAQ:ADTX) saw a significant growth in short interest in October. As of October 31st, there was short interest totalling 910,800 shares, a growth of 102.2% from the October 15th total of 450,400 shares. Based on an average daily volume of 2,420,000 shares, the days-to-cover ratio is currently 0.4 days. Approximately 10.4% of the company’s stock are short sold.

Insider Activity

In related news, major shareholder Financial Lp Hrt sold 25,534 shares of the company’s stock in a transaction on Wednesday, October 16th. The stock was sold at an average price of $1.17, for a total transaction of $29,874.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.72% of the company’s stock.

Aditxt Stock Performance

NASDAQ:ADTX opened at $0.37 on Wednesday. Aditxt has a 52 week low of $0.35 and a 52 week high of $380.00. The firm has a 50-day moving average price of $6.82 and a two-hundred day moving average price of $43.66.

Aditxt (NASDAQ:ADTX) last issued its quarterly earnings results on Monday, August 19th. The company reported ($167.60) EPS for the quarter. The company had revenue of $0.04 million during the quarter.

Aditxt Company Profile

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.